{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:57:15Z","timestamp":1791118635630,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Science Council (NSC)","award":["98A1-VCSP01-014"],"award-info":[{"award-number":["98A1-VCSP01-014"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.vaccine.2011.04.010","type":"journal-article","created":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T15:33:01Z","timestamp":1303227181000},"page":"4362-4372","source":"Crossref","is-referenced-by-count":164,"title":["Identification and characterization of a cross-neutralization epitope of Enterovirus 71"],"prefix":"10.1016","volume":"29","author":[{"given":"Chia-Chyi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Hsiang","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Pei","family":"Lien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Jen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Yuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Shin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hung","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wun-Syue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate Hsuen-Wen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Sia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pele","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.04.010_bib0005","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJM199909233411301","article-title":"for the Taiwan Enterovirus Epidemic Working Group An epidemic of enterovirus 71 infection in Taiwan","volume":"341","author":"Ho","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1586\/erv.09.152","article-title":"Development of enterovirus 71 vaccines","volume":"9","author":"Lee","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-6976.2002.tb00601.x","article-title":"An overview of the evolution of enterovirus 71 and its clinical and public health significance","volume":"26","author":"McMinn","year":"2002","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0020","first-page":"57","article-title":"Enterovirus 71 in the Asia-Pacific region: an emerging cause of acute neurological disease in young children","volume":"8","author":"McMinn","year":"2003","journal-title":"Neurol J Southeast Asia"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0025","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S1474-4422(08)70207-2","article-title":"Enterovirus 71 infection: a new threat to global public health?","volume":"7","author":"Qiu","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0030","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/infdis\/129.3.304","article-title":"An apparently new enterovirus isolated from patients with disease of the central nervous system","volume":"129","author":"Schmidt","year":"1974","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0035","doi-asserted-by":"crossref","unstructured":"Xu J, Qian Y, Wang S, Serrano JMG, Li W, Huang Z, et al. EV71: an emerging infectious disease vaccine target in the Far East? Vaccine; doi:10.1016\/j.vaccine.2010.03.003.","DOI":"10.1016\/j.vaccine.2010.03.003"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0040","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1128\/JCM.00630-09","article-title":"Reemergence of enterovirus 71 in 2008 in Taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008","volume":"47","author":"Huang","year":"2009","journal-title":"J Clin Mincrobiol"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0045","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/jmv.20534","article-title":"Evolution of EV71 genogroup in Taiwan from 1998 to 2005: an emerging of subgenogroup C4 of EV71","volume":"78","author":"Lin","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0050","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0168-1702(95)00087-9","article-title":"Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus","volume":"39","author":"Brown","year":"1995","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0055","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.vaccine.2008.03.041","article-title":"Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection","volume":"26","author":"Chen","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0060","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/JVI.00999-09","article-title":"Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyetitis against disease","volume":"84","author":"Ong","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0065","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1479-0556-5-6","article-title":"DNA vaccine constructs against enterovirus 71 elicit immune response in mice","volume":"5","author":"Tung","year":"2007","journal-title":"Genet Vaccines Ther"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0070","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1016\/j.vaccine.2004.05.037","article-title":"Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development","volume":"22","author":"Wu","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0075","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.vaccine.2008.01.058","article-title":"Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge","volume":"26","author":"Chung","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0080","first-page":"794","article-title":"Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71","volume":"15","author":"Nishimura","year":"2009","journal-title":"Mat Med"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0085","first-page":"798","article-title":"Scavenger receptor B2 is a cellular receptor for enterovirus 71","volume":"15","author":"Yamayoshi","year":"2009","journal-title":"Mat Med"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0090","first-page":"09091","article-title":"Biochemical characterization of E. coli expressed protective antigen Ag473 of N. meningitides group B","author":"Sung","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0095","first-page":"493","article-title":"A simple method of estimating 50 percent end-points","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0100","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"Kohler","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0105","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/IAI.61.5.1867-1872.1993","article-title":"Identification of surface-exposed B-cell epitopes recognized by H Influenzae type b P1-specific monoclonal antibody","volume":"61","author":"Panezutti","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virusres.2006.12.005","article-title":"Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides","volume":"125","author":"Foo","year":"2007","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0115","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.micinf.2007.06.002","article-title":"Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide","volume":"9","author":"Guang","year":"2007","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2011.04.010_bib0120","doi-asserted-by":"crossref","first-page":"14587","DOI":"10.1016\/S0021-9258(18)63732-9","article-title":"The Canyon Hypothesis: hiding the host cell receptor attachment site on a viral surface from immune surveillance","volume":"264","author":"Rossmann","year":"1989","journal-title":"J Biol Chem"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11005202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11005202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T22:10:04Z","timestamp":1637532604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11005202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":24,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0264410X11005202"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.04.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}